Seizures Flashcards
(49 cards)
Definitions
Seizures: excessive electrical discharge of cortical neurons resulting in disruption of brain fxn and change in behavior-> 10% of gen pop will have atleast one seizure in their lifetime
Epilepsy: two or more unprovoked seizures-> 125,000 new cases per yr-> affect ~2 mill pple in US
Mechanisms of seizures
- Abnormal firing of neurons-> increased excitability, ion channels (Na, Ca)
- Increased excitatory amino acids-> Glutamate, aspartate
- Decreased inhibitory process-> GABA
- Interference w/ metabolic processes
Classification of seizures
- Focal seizures: Old classification= partial
- Generalized seizures: involve both hemispheres of the brain from the beginning of seizure
- Unknown onset: newer term from International League Against Epilepsy (ILAE)-> includes: tonic-clonic, atonic, and epileptic spasms
Exitatory vs Inhibitory factors
Excitatory:
-Glutamatergic neurons
-Mod of the release of excitatory nt glutamate
-Na channels
-AMPA receptors and Kainate receptors (coupled to K+ and Ca 2+ channels)
Inhibitory:
GABAergic neurons
GABAa receptors
GABA
Focal vs Generalized seizures - summary
good summary
MOA targets of antiseizure drugs
- Voltage-gated ion channels
- Inhibition of GABA
- Synaptic release components
- Ionotropic glutamate receptors
- Disease specific targets
- mixed/unknown
Anticonvulsant MOA
“spectrum” of antiseizure drug activity
Narrow spectrum: designed for specific seizure types-> approp if seizures occur in one specific part of the brain on a regular basis
Broad spectrum: designed to prevent seizures in more than one part of the brain-> tx more than one seizure subtype
Tx of epilepsy- principles
must be individualized
establish the diagnosis (type of seizure)
select apprp drug for seizure type-> efficacy and SE
Establish therapeutic goals
Strive for monotherapy in seizure control
Anticipate age-related changes in drug response
-pharmacokinetic differences
-pharmacodynamic differences
tx of epilepsy choosing AED
Antiepileptic drug:
Efficacy
safety
cost (generic formulations of older drugs)
drug interactions
dosing frequency
dosage form
-ease of swallowing
-liquid forms
-mixing w/ food
HIGH MED INTERACTIONS + DIZZY+ GI ISSUES + DROWSY
tx of epilepsy monitoring
Monitoring: important for management of most AED
Start at initiation and in early stages of tx
DRUG LEVELS ARE A THERAPEUTIC GUIDELINE-> NOT A HARD AND FAST RULE-> may see response @ concentrations “below” or “above” the therapeutic range-> always combine w/ clinical assessment-> expensive and may not be necessary in all pts
Blood
LFTs
CBC
Problems w/ some traditional 1st gen AEDs
poor water solubility
extensive protein-binding
autoinduction of cytochrome p450 system (carbamazepine)
many drug-drug interactions (all)
Phenobarbital- schedule lV drug
AE of antiseizure meds
GI (N/V)
Sedation
Ataxia
Rash
Hyponatremia
weight gain or loss
teratogenicity
osteoporosis
summary= DIZZINESS, DROWSINESS, GI
Pharmacokinetics of AEDs
gray= 1st gen higher protein binding
blue= 2nd gen mod
green= 3rd gen Low protein binding
Phenobarbital (PB)
brand name: Luminal (1912)
low cost and effective
barbiturate w/ sedative, hypnotic, anticonvulsant properties
Indications:
focal, generalized tonic-clonic seizures, status epilepticus
MOA: enhances the inhibitory actions of GABA neurons
SE: CNS (impaired cognition, sedation, confusion, memory problems, ataxia, hyperactivity in children, CNS depression), blood dyscrasias, osteomalacia, stevens johnson syndrome (SJS), can be abused
Drug interactions: alot of other meds effecting dosing
Primidone (Mysoline)
Indications: tonic-clonic seizures, focal, psychomotor (temporal lobe) seizures
MOA: Initially blocks Na channels but is converted to phenobarbital-> GABA EFFECTS
SE and AE: very sedating like phenobarbital
Monitor: Blood counts and LFTs
Special notes: supplement w/ folic acid
not used much
Benzodiazepines
used for acute/short term use: Generalized anxiety disorder, seizure cessation, alcohol withdrawal, muscle spasms, insomnia
MOA: increase frequency of GABA receptor opening- development of tolerance limits THEIR USE IN CHRONIC TX of EPILEPSY
Lorazepam, diazepam, midazolam= RESCUE MEDICATIONS FOR ACUTE REPETITIVE SEIZURES OR STATUS EPILEPTICUS-> USUALLY REQUIRES TAPERING TO DC IF USED FOR >4 WEEKS
Warnings: sedation, tolerance, hypnosis/amnesia, respiratory depression
PREGNANCY CATEGORY D= AVOID
LIVER DISEASE = AVOID
drug interactions: sedatives and opioids
ANTIDOTE (BENZODIAZEPINE REVERSAL AGENT)-> FLUMAZENIL= can cause withdrawal and seizures
Clonazepam (Klonopin)
Indications: Lennox-Gastaut syndrome, myoclonic seizures, refractory abscence seizures, infantile spasms
SE/AE: salivation, blood dyscrasias
Drug interactions: other seizure meds (may need dose adjustment), other sedatives/hypnotics
Monitoring: CBC, LFTS, renal fxn with long term therapy
MAY PRECIPITATE TONIC-CLONIC SEIZURES
Lennox-Gestaut syndrome
childhood epileptic encephalopathy= multiple seizure types= 10% of epilepsies presenting <5 yo
patho unknown= idiopathic or triggered by underlying disorder (meningitis, tuberous sclerosis, malformations)-> prognosis varies but generally poor, mental regression is common
1st line: Valproate = no optimal therapy highlighted though
specialized anticonvulsants tx:
1. Rufinamide (Banzel)- hepatic metabolism (complex interactions with other seizure meds)-> contra in pts w. FAMILIAL SHORT QT SYNDROME
2. Felbamate (Felbatol) 2nd line for partial/complex seizures-> lot of interactions-> contra in liver dz, blood dyscrasias
3. Clobazam (Onfi, Sympazan)= benzo-> adjunctive tx in pts greater than or equal to 2 yrs-> effect potentiated by drugs like omeprazole
Phenytoin
Brand name: Dilantin
chem structure like barbiturates
indicated: generalized and focal seizures
Moa: block frequency, use, and voltage dependent neuronal Na channels-> limit repetitive firing of AP
Distribution: enters brain rapidly and redistributes-> highly protein bound (90%) rapidly and reversibly bound= AFFECTED BY: LOW ALBUMIN, RENAL FAILURE, AGE, OTHER DRUGS
Metabolism: ELMINATION CHANGES FROM 1ST ORDER (LINEAR) TO ZERO ORDER (NONLINEAR) IN THE THERAPEUTIC RANGE
increases in pregnancy-> DO NOT USE IN PREGNANCY (FETAL HYDANTOIN SYNDROME (CLEFT PALATE, CONGENITAL HEART DZ, INTELLECTUAL DISABILITY AND OTHERS))
BBW: administration of IV FORM-> DO NOT EXCEED 50 MG/MIN IN ADULTS OR 1TO 3 MG/KG/MIN-> RISK OF SEVERE HTN AND CARDIAC ARRHYTHMIAS
SE:
NYSTAGMUS
LETHARGY
COGNITIVE IMPAIRMENT
GINGIVAL HYPERPLASIA
AE: Low / med/high/ severe -> no numbers needed
Fosphenytoin (Cerebryx)
water soluble prodrug of phenytoin (replaced phenyt for IV)
used in acute attacks status epilepticus or as seizure prophylaxis-> used as a loading dose when starting phenytoin
AE: Cerebellar symptoms (ataxia, vertigo, nystagmus, diplopia), pruritis, burning sensation
bbw like phenytoin
Carbamazepine (CBZ)
Brand names: Tegretol, Carbatrol
MOA: primarily via inhibition of voltage gated NA channels
also used for bipolar disorder and trigeminal neuralgia
unique metabolism: Autoinduction (drug induces CYP450 and increases its own metabolism)
Drug interactions:
CBZ= enzyme inducer-> other drugs may induce or inhibit metab-> sedative
AE:
common: HYPONATREMIA, nvd, HA, dizzy, blurred vision
rare: STEVENS JOHNSON/TOXIC EPIDERMAL NECROLYSIS-> HLA-B 1502 OR HLA-A 3101 ASIAN POPULATIONS
Pt ed: DO NOT CRUSH OR CHEW-> “GHOST” OF SHELL IN STOOL W/ Tegretol XR
carbatrol can be opened and mixed w/ food
exposure to heat and humidity may harden tablets-> decreasing bioavailability
newer drug: Oxcarbazepine (Trileptal) se same but No autoinduction still high interactions
Oxcarbazepine (Trileptal)
Derived from carbamazepine-> fewest drug ineractions-> less potent than carbamazepine
Indications: focal and generalized tonic-clonic seizures, neuropathic pain, bipolar disorder
MOA: Blocks Na+ channels
SE: sedation, HA, dizziness, rash, vertigo, ataxia, nausea, hyponatremia (more common w/ trileptal vs. carbamazepine)
AE: SJS/TEN
drug interactions: other AEDs and verapamil
improved SE profile over carbamazepine bc NOT AN ENZYME INDUCER BC DIFF SIDE CHAIN WHICH ALLOWS IT TO BE METABOLIZED AND ELIMINATED DIFFERENTLY
Hyponatremia assoc w/ Oxcarbazepine and Carbamazepine
well described AE
PT MAY BE ASYMPTOMATIC-> may develop over the first few months of therapy
monitoring: BASELINE AND @ THERAPEUTIC LEVEL and IF DEVELOP SXS OF HYPONATREMIA WHILE ON CHRONIC THERAPY
RF: older age, higher serum level of oxcarbazepine/carb, on >1 drug for seizure, concurrent use of antihtn meds (diuretics mainly), history of hyponatremia w/ either drug